Pharmaceutical

Category

Kalvista Pharmaceuticals Update

As reported in Citizen Tribune, KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company, focused on the discovery, development, and commercialization of small molecule protease inhibitors, today provided a development update on its oral...

Pin It on Pinterest